Endorine Metabolism Medicince is categorized under Diabetes Doctors in Kennewick, WA and active since 2007.
Endorine Metabolism Medicince was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Diabetes Doctors business, which does work in the B2C market, and is classified as a Diabetes Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Mary C Newman at the company’s single location by writing to 1410 North Pittsburg St, Kennewick, Washington WA 99336 or by phoning (509) 783-1148. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Endorine Metabolism Medicince |
| Contact Person: | Mary C Newman |
| Address: | 1410 North Pittsburg St, Kennewick, Washington 99336 |
| Phone Number: | (509) 783-1148 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Diabetes Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Endorine Metabolism Medicince was started in 2007 to provide professional Diabetes Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Mary C Newman for inquiries that concern Endorine Metabolism Medicince by calling the company number (509) 783-1148, as your correspondence is most welcome. Additionally, the physical location of the single location of Endorine Metabolism Medicince can be found at the coordinates 46.226561,-119.240312 as well as the street address 1410 North Pittsburg St in Kennewick, Washington 99336.
For its online presence, you may visit Endorine Metabolism Medicince’s website at and engage with its social media outlets through on Twitter and on Facebook.